Daiwa Securities Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Sell |
321
-10,189
| -97% | -$127K | ﹤0.01% | 1181 |
|
|
2025
Q1 | $48K | Sell |
10,510
-376
| -3% | -$1.72K | ﹤0.01% | 1024 |
|
|
2024
Q4 | $61K | Sell |
10,886
-740
| -6% | -$4.15K | ﹤0.01% | 1044 |
|
|
2024
Q3 | $56K | Sell |
11,626
-468
| -4% | -$2.25K | ﹤0.01% | 1059 |
|
|
2024
Q2 | $59K | Buy |
12,094
+5,723
| +90% | +$27.9K | ﹤0.01% | 1082 |
|
|
2024
Q1 | $85K | Sell |
6,371
-401
| -6% | -$5.35K | ﹤0.01% | 1058 |
|
|
2023
Q4 | $94K | Buy |
6,772
+1,759
| +35% | +$24.4K | ﹤0.01% | 1017 |
|
|
2023
Q3 | $66K | Hold |
5,013
| – | – | ﹤0.01% | 1041 |
|
|
2023
Q2 | $94K | Buy |
5,013
+4,792
| +2,168% | +$89.9K | ﹤0.01% | 1014 |
|
|
2023
Q1 | $3K | Hold |
221
| – | – | ﹤0.01% | 1188 |
|
|
2022
Q4 | $4K | Hold |
221
| – | – | ﹤0.01% | 1165 |
|
|
2022
Q3 | $8K | Buy |
221
+80
| +57% | +$2.9K | ﹤0.01% | 1134 |
|
|
2022
Q2 | $2K | Hold |
141
| – | – | ﹤0.01% | 1245 |
|
|
2022
Q1 | $3K | Hold |
141
| – | – | ﹤0.01% | 1225 |
|
|
2021
Q4 | $5K | Buy |
+141
| New | +$5K | ﹤0.01% | 1197 |
|